On the other hand, mTORC2 were not strongly interacting with GSN, MYH9, as well as AKT, a known mTORC2 substrate, in low-grade glioma cell lines (Supplementary Fig. 3B). This evidence concerns the gene MYH9 and central nervous system cancer.